TheraRadar
← Back
Data updated: Mar 29, 2026

ORIENT PHARMA CO LTD

CardiovascularInfectious DiseaseDermatology
Generics

ORIENT PHARMA CO LTD is a generic drug manufacturer focused on Cardiovascular, Infectious Disease, Dermatology.

2014
Since
5
Drugs
-
Trials
32
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

VANCOMYCIN HYDROCHLORIDE 2025-10-02
PITAVASTATIN CALCIUM 2025-06-13
Labeling
VANCOMYCIN HYDROCHLORIDE 2025-05-29
Labeling
VANCOMYCIN HYDROCHLORIDE 2025-03-21
CARISOPRODOL 2024-11-14
Labeling
PITAVASTATIN CALCIUM 2024-11-04
Labeling
EZETIMIBE 2024-10-22
Labeling
EZETIMIBE 2024-10-22
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 36%
1 drugs Phase 3: 1
Infectious Disease 21%
1 drugs
Dermatology 21%
1 drugs
Metabolic 21%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

B BRAUN specialty
Infectious Disease, Dermatology, Metabolic, Cardiovascular
Merck big-pharma
Infectious Disease, Cardiovascular, Metabolic
Baxter specialty
Infectious Disease, Cardiovascular, Dermatology
Johnson & Johnson big-pharma
Infectious Disease, Cardiovascular, Metabolic
Bayer big-pharma
Cardiovascular, Dermatology, Metabolic